1. Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313 by Michael A. Pulsipher, Kenneth M. Boucher, Donna Wall, Haydar Frangoul, Michel Duval, Rakesh K. Goyal, Peter J. Shaw, Ann E. Haight, Michael Grimley, Stephan A. Grupp, Morris Kletzel, and Richard Kadota Blood Volume 114(7):1429-1436 August 13, 2009 ©2009 by American Society of Hematology

2. EFS and OS. The solid line represents EFS; dashed line, OS. Events included relapse, rejection, and death in remission. Michael A. Pulsipher et al. Blood 2009;114:1429-1436 ©2009 by American Society of Hematology

3. OS with and without a history of previous myeloablative transplantation. Michael A. Pulsipher et al. Blood 2009;114:1429-1436 ©2009 by American Society of Hematology

4. OS in patients without previous TBI by the presence or absence of measurable disease. Michael A. Pulsipher et al. Blood 2009;114:1429-1436 ©2009 by American Society of Hematology